Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04856332
Other study ID # ET19-193 - VIK-e2
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 24, 2021
Est. completion date November 30, 2023

Study information

Verified date September 2022
Source Centre Leon Berard
Contact METZGER Séverine
Phone +33 4.78.78.27.86
Email severine.metzger@lyon.unicancer.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The intensive treatments of certain cancers and haemopathies require the implementation of a protective isolation from external micro-organisms for a period of several weeks. This isolation implies a limitation of visitors and sometimes prohibits access to young children. This raises questions concerning the maintenance of family links, and in particular the parent-child relationship as well as the psychological and emotional isolation of hospitalised patients and the resulting psychological effects.


Description:

Telepresence robots are increasingly used as a means of remote communications, especially for teleconsultations and/or access to various public services (cultural events, education, etc.). In the context of long-term hospitalisation, they can be used for various purposes, such as access to cultural events, university activities, contact with patient's home and maintenance of family links. Some studies have analyzed the use of these robots and their effects in academic settings or the suitability of their use with elderly populations for continuing care. To our knowledge, no study has evaluated the interest for the parent-child relationship of the use of a telepresence robot during the hospitalisation in protective isolation for a long period of a patient with young child(ren). We propose to conduct this observational, multi-center prospective study aiming at evaluating the parent-child relationship following the setting up of a mobile telepresence robot for patients with children aged 15 years or less and hospitalised in long-term protective isolation.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date November 30, 2023
Est. primary completion date June 24, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age= 18 - Patient with at least one child aged 15 or under - Pathology requiring a prolonged hospitalization in protective isolation - Consent dated and signed Exclusion Criteria: - Impaired cognitive functions - Performance Status -Eastern Cooperative Oncology Group (PS-ECOG) = 4 - Difficulties in speaking and understanding French - Patient under guardianship or curatorship

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Telepresence robot installed at child's home during parent's hospitalisation
Telepresence robot installed at child's home during parent's hospitalisation in long term protective isolation for maintaining parent-child ink (only children aged 15 years or less are concerned)

Locations

Country Name City State
France Centre Hospitalier Lyon Sud Lyon
France Centre Leon Berard Lyon
France Institut Paoli Calmettes Marseille

Sponsors (1)

Lead Sponsor Collaborator
Centre Leon Berard

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of the use of a telepresence robot on the parent-child relationship in maintaining parenthood during parent's hospitalisation in long-term protective isolation Observation of communications between the hospitalised patient and his/her chid(children) by a specialist in human and social sciences Through study completion, an average of 3 months
Primary Evaluation of the use of a telepresence robot on the parent-child relationship in maintaining parenthood during parent's hospitalisation in long-term protective isolation Interview with the hospitalised patient (parent) by a specialist in human and social sciences Through study completion, an average of 3 months
Secondary Evaluation of the experience linked to the robot availability on the concerned persons (patient, children, person on charge of children) Interview with the hospitalised patient (parent) and the person in charge of children by a specialist in human and social sciences Through study completion, an average of 3 months
Secondary Evaluation of patient's satisfaction Interview with the hospitalised patient (parent) and the person in charge of children by a specialist in human and social sciences Through study completion, an average of 3 months
Secondary Evaluation of the impact of robot use on patient's coping strategies (adaptation and adjustment to illness and hospitalisation) Interview with the hospitalised patient and the person in charge of children by a specialist in human and social sciences Through study completion, an average of 3 months
Secondary Evaluation of patient's experience of hospitalisation Interview with the hospitalised patient and the person in charge of children by a specialist in human and social sciences Through study completion, an average of 3 months
Secondary Evaluation of the impact of the robot's presence at home on the children and the person in charge of the children during patient's hospitalisation Interview with the hospitalised patient and the person in charge of children by a specialist in human and social sciences Through study completion, an average of 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases